FDA Clears SmartSpeed Precise MRI Software from Philips
The deep learning reconstruction software reportedly facilitates accelerated MRI scanning and significantly enhanced image sharpness.
The Food and Drug Administration (FDA) has granted 510(k) clearance for SmartSpeed Precise software, which may enable significantly reduced scan times and advanced image clarity for magnetic resonance imaging (MRI).
Emphasizing a one-click workflow, the SmartSpeed Precise MRI software combines the Compressed SENSE acceleration technology with dual artificial intelligence (AI) engines for denoising and image sharpening, according to Philips, the manufacturer of SmartSpeed Precise.
Here one can see images from a seven-second brain MRI exam performed with the use of the recently FDA-cleared SmartSpeed Precise software. (Images courtesy of Philips.)
Philips maintained the use of SmartSpeed Precise MRI software, which is available for Philips 1.5T and 3T MRI system, enables a threefold acceleration of MRI scan time and up to an 80 percent improvement in image sharpness.
“SmartSpeed Precise helps us do what was previously thought impossible—deliver sharper, faster MRI with less effort,” added Julian Luetkens, M.D., a professor of radiology at University Hospital Bonn in Bonn, Germany. “In breast MRI, we saw acquisition times reduced by up to 50%, with image quality improving compared to previous Compressed SENSE protocols. That’s a game-changer.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
